Dexlab makes launching on Solana easy with a token minting lab, a launchpad and a dedicated DEX for all listings
What is Dexlab? Dexlab is an integrated DEX platform that provides a GUI to issue Solana-based tokens without the need to code. It leverages the Serum Decentralized Exchange (DEX)'s central order book to support ultra-fast transactions, shared liquidity, and new features for monetization.
The SPL CLI is the primary method to create and manage Solana tokens. Currently, it lacks the linkage to be able to manage environment settings, token sales, market listings, and token information. With Dexlab's GUI, one will be able to manage these settings, and be able to do everything from token issuance to adjusting utility settings.
Leveraging in-depth analyst evaluations, we have distilled key insights from expert assessments to provide a compelling outlook for DXL. Our analysts point to weakening fundamentals and unfavorable market sentiment, indicating considerable downside risk in the near term. Based on this in-depth expert analysis, we hold a highly cautious view of this stock. Our conclusion: DXL is a Strong Sell candidate.
DXL stock price ended at $0.000219 on 木曜日, after dropping 0.93%
On Apr 09, 2026 00:00, the price of DXL fell by 0.93%, dropping from $0.000223 to $0.000219 with 24h trading volume reaching $3 DXL.